---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-017134"
form_type: "8-K"
ticker: "LIMN"
cik: "0001971387"
company_name: "Liminatus Pharma, Inc."
filed_at: "2026-02-18T23:59:59+00:00"
generated_at: "2026-05-16T02:10:31.959263+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Liminatus Pharma prices $4.0M public offering of common stock and warrants

## Summary
- Offering of 13.8M shares/pre-funded warrants and warrants for up to 20.7M shares at combined $0.29 per unit.
- Gross proceeds ~$4.0M; net proceeds ~$3.46M after placement agent fees and expenses.
- Warrants exercisable immediately at $0.29 per share, expire 5 years from issuance.
- Placement agent Maxim Group LLC receives 8% cash fee, $100K expense reimbursement, and 690,650 warrant shares at $0.319.
- Directors and officers subject to 180-day lock-up; company restricted from certain equity issuances for 180 days.

## SEC filing metadata
- accession: 0001104659-26-017134
- form_type: 8-K
- ticker: LIMN
- cik: 0001971387
- company_name: Liminatus Pharma, Inc.
- filed_at: 2026-02-18T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1971387/000110465926017134/0001104659-26-017134-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1971387/000110465926017134/tm266571d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-017134
- JSON: https://secwatch.observer/filing/0001104659-26-017134.json
- Plain text: https://secwatch.observer/filing/0001104659-26-017134.txt

## Key facts
- Material Agreements
  Liminatus Pharma, Inc. entered into Purchase Agreement with certain purchasers party thereto (effective 2026-02-17).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: certain purchasers party thereto
  - Effective: 2026-02-17
  source text: the Company entered into a securities purchase agreement (the "Purchase Agreement") with certain purchasers party thereto.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1971387/000110465926017134/0001104659-26-017134-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.